By selecting the Yes option, leaving Amgen.com.sg option you understand that you are leaving the corporate page of Amgen Singapore and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Singapore is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Singapore. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Amgen collaborates with healthcare providers, industry partners, academia, and the community to drive scientific innovation, advance medical breakthroughs, and enhance patient outcomes. Our strategic partnerships with a diverse range of stakeholders focus on accelerating innovation and the growth of biotech startups, fostering collaboration within Singapore’s biotech sector, providing access to treatments for serious illnesses, and building a sustainable and equitable healthcare system in Singapore.
The Amgen x NSG Golden Ticket Program is a partnership between Amgen and NSG BioLabs aimed at supporting innovative biotech startups and fostering sector collaboration in Singapore. The program awards "Golden Tickets" that offer valuable mentorship from Amgen’s network of scientific and business leaders and one-year free access to NSG BioLabs' co-working laboratories and office space. This initiative reflects Amgen’s commitment to advancing Singapore’s biotech landscape by supporting high-growth startups and driving innovation in the region.
Learn more on Amgen’s Golden Ticket program
Amgen leads initiatives such as the Bone Health Alliance and partners with organizations like The Good Life Medical Centre and Frontier Healthcare to promote awareness and preventive measures for bone health. We also collaborate with the Singapore Heart Foundation to enhance efforts in preventing cardiovascular disease among Singaporeans.
Amgen actively supports the development of a highly skilled workforce for Singapore’s biologics manufacturing sector by partnering with the Singapore Economic Development Board (EDB), SkillsFuture Singapore (SSG), Workforce Singapore (WSG), and leading academic institutions.
Through these industry development programs, designed to nurture a future-ready talent pipeline, Amgen strives to transform scientific innovations into life-changing therapies that benefit patients worldwide. has context menu
Amgen's partnership with the Infocomm Media Development Authority (IMDA) focuses on integrating advanced technology into its manufacturing operations. By utilizing IMDA's Open Innovation Platform, a virtual crowdsourcing tool that connects businesses with relevant technology providers, Amgen addresses its technological challenges with innovative solutions, such as enhancing operational efficiencies and worker safety through the use of Autonomous Guided Vehicles (AGVs). Collaborations like these highlight Amgen's commitment to digital transformation and enable us to accelerate our speed to market, ultimately serving more patients.
